IRulya Therapeutics Inc. (IRLA)

IRulya Therapeutics Inc. (IRLA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $35M; returns 1 day +0.8%, 1 week +3.3%.

IRulya Therapeutics Inc. (NASDAQ: IRLA), previously known as Quince Therapeutics (formerly NASDAQ: QNCX), is a clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing targeted therapeutics for rare and debilitating diseases.

Groups IRLA belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Rare Diseases
• Neurological Disorders
• Healthcare
• Neuroscience

IRLA financial model: income statement, cash flow and balance sheet